Multiple Sclerosis Clinical Trial
— KMLOfficial title:
Benefits Evaluation of Selfia® Adapted Underwear for Multiple Sclerosis Patients With Severe to Moderate Handicap Performing Self-catheterization : a Multicenter, Prospective, Uncontrolled and Before/After Study.
NCT number | NCT02889419 |
Other study ID # | RC-P0045 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2017 |
Est. completion date | June 2020 |
Verified date | August 2018 |
Source | Lille Catholic University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
KML is a multicenter, prospective, uncontrolled and before/after study. The study aims to
estimate if the use of Selfia ® adapted underwear reduces the necessary duration for the
realization of self-catheterisation (SC) for patients affected by multiple sclerosis with
severe to moderate disability.
Secondly, the study aims to :
- Estimate the effect of underwear on quality of life, tiredness linked to the act,
comfort in the realization of SC, complications with SC, third party intervention ;
- Collect patients' opinion on the use of the underwear SELFIA ® at the end of the 2nd
week of evaluation ;
- Measure if the patient reused underwear and if he bought it at 6 months and at 1 year
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | June 2020 |
Est. primary completion date | June 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients with multiple sclerosis (MS) according to McDonald criteria - At least 18 years old - Self-catheterization for at least 3 months - Expended Disability Status Scale (EDSS) between 6.0 and 7.5 - Informed consent - Coverage of the social insurance Exclusion Criteria: - MS relapse in the previous month - Patient hospitalized in short stay or aftercare departments, no matter the reason - Morbid obesity (BMI superior to 35) - Understanding disorders preventing an informed consent - EDSS inferior to 6.0 or superior to 7.5 - Patient with home bladder catheter - No capacity to provide a self-catheterisation - Age under 18 years - Pregnant or breast-feeding woman - Patient under legal protection |
Country | Name | City | State |
---|---|---|---|
France | Clinique Saint-Augustin | Bordeaux | |
France | Hôpital Swynghedauw - CHRU de Lille | Lille | |
France | Groupement des Hôpitaux de l'Institut Catholique de Lille | Lomme | Nord Pas-de-Calais |
France | Cabinet médical de Neurologie | Lyon | |
France | Hôpital Saint-Jacques - CHU Nantes | Nantes | |
France | Pôle MPR Saint Hélier | Rennes |
Lead Sponsor | Collaborator |
---|---|
Lille Catholic University |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Average time spend for the realization of a self-catheterisation, from undressing to dressing, measured by a chronometer provided to the patient | 17 days | ||
Secondary | Measure of the quality of life | Specific scale adapted for the studied population: Qualiveen (self-questionnaire for MS patients with urinary disorders) | 17 days | |
Secondary | Measure of fatigue for every SC | EVA scale | 17 days | |
Secondary | Comfort linked to SC | EVA scale for pain linked to undressing / dressing | 17 days | |
Secondary | Consequences from SC complications | Number of bleeding, EVA scale for the pain linked to the introduction / withdraw of the urinary catheter, | 17 days | |
Secondary | Number of documented urinary infections | 17 days | ||
Secondary | Number of self-catheterisation or hetero-catheterisation per day | 17 days | ||
Secondary | Opinion of the patient (favorable/non favorable) on the use of underwear Selfia ® | at 6 months and at 1 year | ||
Secondary | Re-use (yes/no) of underwear with or without purchase (yes/no) | at 6 months and at 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |